Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 361

Results For "patients"

3865 News Found

Health Sensei wins Stanford Seed Spark competition
Startup | September 24, 2021

Health Sensei wins Stanford Seed Spark competition

Seed Spark is an online entrepreneurship program offered by Stanford Seed. Health Sensei emerged as a winner competing with 86 startups from their May-Aug 2021 graduating cohort


Aurobindo subsidiary submits MAA for oncology biosimilar
Biotech | September 23, 2021

Aurobindo subsidiary submits MAA for oncology biosimilar

CuraTeQ Biologics is on track for filing a second oncology biosimilar


Roche launches three respiratory test panels on Cobas 6800/8800 Systems in CE markets
Medical Device | September 23, 2021

Roche launches three respiratory test panels on Cobas 6800/8800 Systems in CE markets

Three new molecular diagnostic test panels for influenza and other common respiratory illnesses can be run together or alone using one patient sample


Health Minister Mansukh Mandaviya releases post-Covid sequelae modules
Public Health | September 23, 2021

Health Minister Mansukh Mandaviya releases post-Covid sequelae modules

These modules will act as a guide to doctors and health care workers to deal with post-Covid-19 issues


Terumo India releases stamp to commemorate the centenary of Terumo Corporation
Events | September 22, 2021

Terumo India releases stamp to commemorate the centenary of Terumo Corporation

Terumo’s first product was the domestically produced, safe, high-quality thermometer. The company has since supported the healthcare ecosystem worldwide


Boehringer Ingelheim acquires Abexxa Biologics to advance its cancer research
Biotech | September 22, 2021

Boehringer Ingelheim acquires Abexxa Biologics to advance its cancer research

The addition of Abexxa’s expertise complements Boehringer Ingelheim’s current approaches to the treatment of difficult-to-treat solid cancers and especially those resistant to available immunotherapies


DCGI approves Ampio Pharma’s Phase II trials to tackle Covid-19 induced respiratory distress
Biotech | September 22, 2021

DCGI approves Ampio Pharma’s Phase II trials to tackle Covid-19 induced respiratory distress

Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs


MetroMedi ties up with BMS Fit Club for diabetes management
Healthcare | September 22, 2021

MetroMedi ties up with BMS Fit Club for diabetes management

The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue


U.S. FDA approves Samsung Bioepis and Biogen’s BYOOVIZ biosimilar
Drug Approval | September 21, 2021

U.S. FDA approves Samsung Bioepis and Biogen’s BYOOVIZ biosimilar

It becomes the first ophthalmology biosimilar to gain FDA approval in the United States


HUTCHMED initiates a Japan bridging study to Support Surufatinib
Biotech | September 21, 2021

HUTCHMED initiates a Japan bridging study to Support Surufatinib

Surufatinib is the third potential new medicine discovered by the company to enter into clinical development in Japan